Octagon Capital Advisors LP
Annual return '25
+69.8%
SPY '25
+17.7%
Alpha
+52.1ptsvs SPY
Invested
$903.6M
Holdings
29
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 91%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$DNTH
DIANTHUS THERAPEUTICS INC
Held since at least Q1 2024
18.1%
02
$COGT
COGENT BIOSCIENCES INC
Held since at least Q1 2024
10.0%
03
$ABVX
ABIVAX SA
Held since at least Q1 2024
8.3%
04
$ALMS
ALUMIS INC
Held since at least Q1 2024
6.9%
05
$DFTX
DEFINIUM THERAPEUTICS INC
Held since at least Q1 2024
5.1%
06
$AVBP
ARRIVENT BIOPHARMA INC
Held since at least Q1 2024
5.0%
07
$TSHA
TAYSHA GENE THERAPIES INC
Held since at least Q1 2024
4.4%
08
$KYMR
KYMERA THERAPEUTICS INC
Held since at least Q1 2024
3.9%
09
$MIRM
MIRUM PHARMACEUTICALS INC
Held since at least Q1 2024
3.5%
10
$BIOA
BIOAGE LABS INC
Held since at least Q1 2024
3.4%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 10:19 UTC.